Skip to main content
. 2020 Aug 24;16:304. doi: 10.1186/s12917-020-02525-x

Table 3.

Reversal drug requirements, duration of recovery from reversal and recovery temperature

Group n Time from reversal to recovery (min) Patients requiring reversal Temperature at recovery (F/C)
Feline OVH 26 12 (3–60)

24/26 (92%)

Atipamezole IM n = 24 (once)

99.1 (95.7–106.0) F

37.3 (35.4–41.1) C

Feline Castration 22 20 (4–50)

22/22 (100%)

Atipamezole IM n = 21 (once)

Atipamezole IM n = 1 (twice)

101.9 (99–102.7) F

38.8(37.2–39.3) C

Canine OVH 28 12 (4–30)

25/28 (89%)

Atipamezole IM n = 24 (once)

Atipamezole IM n = 1 (twice)

102.6 (97.3–104.1) F

39.2 (36.3–40.1) C

Canine Castration 24 14 (8–83)

22/24 (92%)

Atipamezole IM n = 20 (once)

Atipamezole IM n = 2 (twice)

102.3 (101.2–104) F

39.1 (38.4–40.0) C

Time and temperature are presented as median and range